Asset Dedication’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Asset Dedication's ADPT Position: Q3 2026 in Review
Asset Dedication held its Adaptive Biotechnologies (ADPT) position steady in Q3 2026 at 350 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #793.
Asset Dedication first reported a position in ADPT in Q2 2020 and has held it in 26 quarters since. The position peaked at $51K in Q2 2021. 244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Asset Dedication held 350 shares of Adaptive Biotechnologies worth $10.1K as of Q3 2026.
- Asset Dedication left its Adaptive Biotechnologies share count unchanged in Q3 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #793 holding.
- Asset Dedication first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 26 quarters since.
- Asset Dedication's Adaptive Biotechnologies position peaked at $51K in Q2 2021.
- 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.